Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-20

Clinical Trial Update: Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial evaluating the efficacy and safety of Sanggua Tablets in patients with impaired glucose tolerance and mild type 2 diabetes; recruitment is o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sanggua Tablets

Snippet

Sponsor: Tongji Hospital | Conditions: Diabetes Mellitus, Type 2, Impaired Glucose Tolerance | EARLY_Phase 1 | Status: RECRUITING